The purpose of this study was to investigate the functional role of G-protein-coupled inward rectifier potassium (GIRK) channels in the cardiac ventricle.
Introduction
G-protein-coupled inward rectifier potassium (GIRK) channels are regulated by G-protein-coupled receptors (GPCRs). Four GIRK channel family members (GIRK1-GIRK4 ¼ Kir3.1-Kir3.4) have been identified in mammals, but only GIRK1 and GIRK4 are expressed in the heart, where GIRK1/4 heteromers form the molecular basis of the I K,ACh current. 1, 2 GIRK channels are important for modulating heart rate, for stabilizing resting membrane potential (RMP) in atria, and for atrial action potential repolarization via parasympathetic stimulation in the heart. 3, 4 Activation of cardiac GIRK channels by acetylcholine (ACh), adenosine, and adenosine triphosphate (ATP) mediates negative chronotropic and dromotropic effect in sinoatrial node (SAN), atrioventricular node (AVN), atria, and in the cardiac Purkinje system. 5 -9 GIRK1/4 channels have previously in rat andferretbeenfoundpredominantlyexpressedinSAN,AVN,atriaandPurkinje fibres, and weakly expressed in ventricles compared with atria. 10, 11 However, we have recently found the expression of GIRK1/4 protein in the human ventricle to be 50% of that in the atrium. 12 Despite the previously reported small density of ventricular GIRK current, substantial effects of ACh and adenosine on action potentials in isolated ventricular myocytes in different species have been described. 11, 13 In human ventricular myocytes, application of ACh resulted in shortening of action potential duration (APD). 13 In agreement with this, a study by Dobrzynski et al. 11 showed that both ACh and adenosine resulted in APD shortening in ferret ventricular myocytes. However, neither of these studies demonstrated that the APD shortening was due to direct GIRK channel activation. Hence, further investigations are required to fully understand the functional role of GIRK current in ventricular repolarization.
In our recent study, we identified a mutation in KCNJ5, the gene encoding GIRK4 channel, in a large long-QT syndrome (LQTS) family. 12 Functional investigation revealed a loss-of-function phenotype resulting from reduced plasma membrane expression, thereby linking the mutation to congenital LQTS. This suggests GIRK channels to have a potential role in ventricular repolarization. In line with this, Beckmann et al. 14 demonstrated that GIRK current carried by GIRK1/4 is masked by the presence of a large I K1 in ventricles, indicating that GIRK current might have been underestimated in ventricles. Furthermore, a recent review has suggested a widespread location of parasympathetic nerves and a relatively dense parasympathetic innervation of ventricular muscle in a range of mammals, including humans. 15 This indicates that ventricular GIRK channels may also be directly regulated by parasympathetic stimulation. Adenosine mediating its effect via ventricular A1 receptors 11 and Gi proteins coupled to GIRK channels may likewise be an important ventricular repolarizing mechanism. Taken together, these findings suggest that GIRK current may have an important role in ventricular repolarization and thereby a more prominent physiological and possibly pathophysiological relevance than previously thought.
The purpose of this study was to investigate GIRK channel expression and cellular localization in ventricles in mice, rat, and humans, and to elucidate the functional role of GIRK current in ventricular repolarization using pharmacological tools in ex vivo experiments.
Methods
An expanded methods section is available in the Supplementary material online, methods.
Tissue and animals
Tissue from different regions of the heart from GIRK1 knock-out (KO) mice, GIRK4 KO mice, wild-type (WT) mice (C57BL/6 strain), Sprague-Dawley rats, and humans was used for immunohistochemical experiments. The generation of GIRK1 KO, GIRK4 KO mice was described previously. 4, 16 Healthy human left ventricular tissues from donor hearts that were technically unusable for transplantation (due to logistical, not patient-related, reasons) were used [ethical approval number 4991-0/2010-1018EKU (339/PI/010)]. The investigations conform to the principles outlined in the Declaration of Helsinki and were approved by the Scientific Ethics Committee of Copenhagen and Frederiksberg (protocol reference number KF 01313322).
Male Sprague-Dawley rats (Taconic, Denmark; body weight 350-400 g), GIRK4 KO mice, and WT mice (C57BL/6 strain) were used for ex vivo electrophysiology experiments. Animals were anaesthetized subcutaneously by a mixture of midazolam (2.5 mg/kg), fluanisone (2.5 mg/kg), and fentanyl citrate (0.08 mg/kg), and then heparinized (1000 IU/kg iv). Adequacy of anaesthesia was determined by assessing loss of the pedal reflex. The study protocol was approved by the Danish Research Animal Committee, and all animal experiments in this study were performed in accordance with the Danish legislation of animal use for scientific procedures as described in the 'Animal Testing Act'. The Danish 'Animal Testing Act' fully and extensively covers the requirements included in the Directive 2010/63/EU published by the European Parliament.
Confocal microscopy and imaging
For imaging experiments, rabbit anti-Girk1 (APC-005, 1:100, Alomone Labs), or rabbit anti-Girk1 (P-2360, 1:100, Sigma), or rabbit anti-Girk4 (APC-027, 1:100, Alomone Labs) together with mouse anti-Connexin 43 (Cx43) (35-5000, 1:200, Life Technologies) were used as primary antibodies. As secondary antibodies, an Alexa Fluor w 568-conjugated goat anti-rabbit IgG (1:800, Life Technologies) and Alexa Fluor w 488-conjugated goat anti-mouse IgG (1:200, Life Technologies) were used. 4,6-Diamidino-2-phenylindole (DAPI, Life Technologies) was used to stain the nucleus. For detailed description, see Supplementary material online.
Ex vivo electrophysiology: isolated papillary muscle preparation
The isolated rat papillary muscle experiments were carried out as previously described. 17 Briefly, the left ventricle was cut open and a papillary muscle was removed and superfused with modified Tyrodes solution at 378C in an organ bath. The experiments in mice were performed using isolated right ventricle. Pacing was induced via a bipolar coaxial electrode using pulses of 2 ms duration. A single cell was impaled with a sharpfilamented glass microelectrode and signals were amplified with a biopotential amplifier (Hugo Sachs-Harvard Apparatus GmbH, Germany). For detailed description, see Supplementary material online, Methods.
Ex vivo electrophysiology: isolated Langendorff heart preparation
The Langendorff-perfused heart experiments were carried out as previously described. 18 In brief, isolated rat hearts were perfused at a constant pressure of 80 mmHg with a modified Krebs-Henseleit solution. To achieve stable ventricular paced heart rates, atria were removed. The heart was paced via a bipolar stimulating electrode placed on the right ventricular base with 200 ms cycle length as baseline.
The hearts were randomly assigned to one of the five different groups. Protocols of perfusion are illustrated schematically in Figure 5A . Heart rate, aortic flow rate, aortic pressure, left ventricular end-diastolic pressure, left ventricular developed pressure (LVDP), monophasic action potential, and ECG were continuously recorded throughout the experimental procedures. Data acquisition was performed with a sample rate of 1 kHz by a 16-channel PowerLab system and analysed using the CHART 7.2 Pro software (ADInstruments, UK). For extended description, see Supplementary material online, Methods.
Statistical analysis
All data are presented as means + standard error of the mean (SEM). For statistical analysis, paired t-test or one-way analysis of variance combined with a Bonferroni multiple comparison post hoc test was used. P , 0.05 was considered statistically significant. Graph Pad Prism 5 was used for statistical analysis.
Results

Expression of GIRK4 in mice ventricle
To investigate the specificity of antibodies used in this study, we first conducted immunofluorescence labelling and confocal microscopy experiments using GIRK1 and GIRK4 KO mouse tissue. All confocal microscopy pictures were acquired using the same configurations. Figure 1A and B shows a section of GIRK4 KO atrial and ventricular tissue labelled for GIRK4 and Cx43. In the atrial and ventricular sections and Cx43 show that GIRK4 labelling was not detected in GIRK4 KO atrium and ventricle, whereas Cx43 labelling was located in intercalated discs. In contrast to GIRK4 KO mice, confocal images of GIRK1 KO mice atrial (C) and ventricular (D) tissue sections displayed labelling associated with the outer sarcolemma and the ventricular t-tubular system. Scale bar ¼ 10 mm. of GIRK4 KO mice, GIRK4 labelling was not detected, whereas Cx43 labelling was located in intercalated discs. In contrast to GIRK4 KO mice, GIRK4 labelling was detected in both atrial and ventricular sections of GIRK1 KO mice. Labelling was observed in the outer sarcolemma and the ventricular t-tubular system as previously described. 10, 19 Surprisingly, GIRK4 labelling was also located in intercalated discs ( Figure 1C and D). Cx43 labelling was present in intercalated discs in both atrium and ventricle. For wild-type mice, similar GIRK4 staining results (Supplementary material online, Figure S2 ) were obtained as for GIRK1 KO mice atrial and ventricular sections ( Figure 1C and D) .
The cellular distribution of GIRK1 protein was also addressed with two different commercial antibodies without success. Hence, we focused on GIRK4 expression in the following experiments.
In summary, the experiments demonstrate anti-GIRK4 antibody specificity and specific expression of GIRK4 in mice atria and ventricle.
Expression of GIRK4 in rat and human ventricle
In rat right atrium, GIRK4 labelling was present in intercalated discs and in the outer sarcolemma ( Figure 2A) . In contrast, GIRK4 was co-localized with Cx43 in the left ventricle, suggesting an intercalated disk localization, but undetectable in outer sarcolemma and t-tubules ( Figure 2B) . Figure 3 shows epicardial, mid-myocardial, and endocardial sections of human left ventricle. In epicardial and endocardial sections ( Figure 3A and C ), GIRK4 labelling was strongly present in intercalated discs and, although at lower intensity, present in t-tubules. Surprisingly, GIRK4 labelling was not detected in mid-myocardial sections ( Figure 3B ).
Functional role of GIRK current in rat and mouse ventricle
To investigate the effect of GIRK channel activation and inhibition on ventricular repolarization, we performed experiments on isolated rat papillary muscle. Sharp electrode intracellular recordings provide consistent transmembrane action potential signals with constant morphology, enabling us to evaluate changes in RMP besides APD. Pacing frequency was 1 and 5 Hz. The perfusion protocols are shown in Figure 4A .
Following a 20-min perfusion of the selective adenosine A 1 receptor (A 1 -R) agonist CPA at 100 nM, APD at 90% repolarization (APD 90 ) was decreased from 54.09 + 5.02 to 48.67 + 3.89 ms (P , 0.05) and from 40.64 + 4.59 to 37.98 + 3.90 ms (P , 0.05) at 1 or 5 Hz, respectively ( Figure 4C ). The cell membrane was hyperpolarized following application of CPA. This was observed as a change in RMP, with a hyperpolarization from 279.19 + 1.08 to 283.59 + 1.03 mV (P , 0.05) and from 279.12 + 2.76 to 286.46 + 2.61 mV (P , 0.01), at 1 or 5 Hz, respectively ( Figure 4C ). The GIRK channel blocker tertiapin-Q (TTQ) at 20 nM was added to the perfusate to block GIRK currents. Co-application of TTQ not only opposed the CPA-induced decrease in APD, from 48.67 + 3.89 to 59.76 + 5.27 ms (P , 0.01) and from 37.98 + 3.90 to 44.06 + 4.59 ms (P , 0.01), at 1 or 5 Hz, respectively, but actually reversed APD 90 above the control values (P , 0.05 vs. control). In combination with APD recovery, RMP also recovered in response to TTQ at 1 or 5 Hz, respectively. There was no significant change in upstroke amplitude throughout the experiments (data not shown).
GIRK channels may have a basal activity in the absence of receptor signalling, 1,20 -22 so we investigated the effect of GIRK channel inhibition, in the absence of exogenous receptor activation. Following a 30-min perfusion of 20 nM TTQ, APD 90 was increased from 54.12 + 3.99 to 61.93 + 5.34 ms (P , 0.01) and from 32.18 + 3.20 to 35.78 + 3.24 ms (P , 0.05), at 1 or 5 Hz, respectively ( Figure 4D) . The cell membrane was depolarized following application of TTQ at 1 Hz pacing frequency: the RMP depolarized from 280.18 + 1.18 to 276.30 + 1.31 mV at 1 Hz (P , 0.01), whereas no significant change was observed at 5 Hz ( Figure 4D ). There was also no significant difference in upstroke amplitude throughout the experiments (data not shown).
Four time-matched control experiments were also conducted showing that APD 90 and RMP were stable throughout the experiment ( Figure 4E) .
To confirm the effects of GIRK channel activation on the ventricular electrophysiological parameters observed above, we also performed experiments using GIRK4 KO mice and WT mice. Pacing frequency was 5 Hz. Following a 5-min perfusion of ACh, APD 90 was decrease from 26.94 + 0.65 to 24.45 + 0.66 ms (P , 0.0001) ( Figure 5 ) in WT mice. The cell membrane was hyperpolarized following application of stained for GIRK4 and Cx43. GIRK4 labelling was strongly present in intercalated discs, and present in t-tubules. In contrast, GIRK4 labelling was not detected in mid-myocardial sections (B). Cx43 was located in intercalated discs in all sections. Scale bar ¼ 10 mm.
ACh from 281.58 + 0.57 to 283.27 + 0.71 mV (P , 0.001) ( Figure 5 ). Co-application of TTQ not only opposed the ACh-induced decrease in APD 90 from 24.45 + 0.66 to 28.36 + 0.86 ms (P , 0.0001), but actually reversed APD 90 above the control values (P , 0.001 vs. control). In combination with APD recovery, RMP also recovered in response to TTQ. In contrast to WT mice, the effect of Ach, and TTQ, was absent in GIRK4 KO mice ( Figure 5 ).
Functional role of GIRK current in ventricle studied on isolated-perfused rat hearts
To confirm the effect of GIRK channel activation and inhibition on ventricular repolarization, as well as to clarify the signalling pathway underlying GIRK channel activation, we further performed experiments on isolated Langendorff-perfused rat hearts. Pacing frequency was set at 5 Hz as baseline. As GIRK channels can be activated via A 1 -R or muscarinic M 2 receptor (M 2 -R), we tested the effect of GIRK channel activation on ventricular repolarization via either A 1 -R or M 2 -R signalling pathways. The experimental protocols are shown in Figure 6A .
Following a 20-min perfusion of 300 nM CPA, APD 90 was decreased from 49.33 + 1.16 to 40.55 + 0.93 ms (P , 0.001), and the effective refractory period (ERP) was decreased from 40.58 + 2.31 to 31.75 + 2.95 ms (P , 0.05) ( Figure 6B) . Co-application of 20 nM TTQ not only opposed APD 90 from 40.55 + 0.93 to 54.38 + 1.54 ms (P , 0.001), but actually reversed APD 90 above the control values (P , 0.05 vs. control). ERP also recovered in response to TTQ from 31.75 + 2.95 to 43.5 + 2.33 ms (P , 0.05). We also studied whether the effect of GIRK channel activation and inhibition on APD was frequency dependent by pacing the heart from a pacing cycle length of 100-400 ms, in 50 ms increment. The results demonstrated that this was not the case (data not shown). To confirm that shortening of APD 90 is due to GIRK channel activation via A 1 -R activation, we performed experiments using the selective A 1 -R antagonist DPCPX. Figure 6C shows APD 90 was decreased from 50.87 + 2.31 to 36.93 + 1.76 ms (P , 0.001) following application of 300 nM CPA. The APD shortening was reversed following a 30-min co-application of 100 nM DPCPX with 300 nM CPA, from 36.93 + 1.76 to 50.53 + 1.90 ms (P , 0.001). The ERP showed a trend towards shortening, although this was not significant, and co-application of DPCPX with CPA partially reversed the ERP shortening. There was no significant change in LVDP and pacing threshold (data not shown).
To test whether GIRK channel activation via M 2 -R also has an effect on ventricular repolarization, M 2 -R agonist ACh was applied. Following a 20-min perfusion of 10 mM ACh, APD 90 was decreased from 56.27 + 2.62 to 40.67 + 3.32 ms (P , 0.001), and the ERP was decreased from 44.83 + 2.34 to 33.17 + 1.56 ms (P , 0.01) ( Figure 6D ). There was also a significant decrease in LVDP (data not shown). Co-application of 20 nM TTQ to block GIRK currents recovered APD 90 from 40.67 + 3.32 to 53.77 + 2.28 ms (P , 0.01), and also recovered the ERP shortening, from 33.17 + 1.56 to 41.83 + 3.01 ms (P , 0.05), but did not recover the LVDP decrease. To confirm that the APD shortening is a direct effect of GIRK channel activation via M 2 -R activation, we further performed experiments using the selective M 2 -R antagonist AF-DX 116, instead of TTQ. Figure 6E shows APD 90 was decreased from 57.64 + 3.46 to 45.84 + 2.94 ms following application of 10 mM ACh (P , 0.01). The APD shortening was recovered following a 30-min co-application of 1 mM AF-DX 116 with 10 mM ACh, from 45.84 + 2.94 to 53.20 + 1.28 ms (P , 0.05). The ERP was also shortened following application of ACh from 41.20 + 1.74 to 32.40 + 1.07 ms (P , 0.01). Co-application of AF-DX 116 with ACh recovered the ERP shortening from 32.40 + 1.07 to 39.20 + 2.04 ms (P , 0.05). There was no significant change in LVDP (data not shown).
To further investigate whether basal activity of GIRK channels contributes to ventricular repolarization, we also performed experiments using TTQ alone. Following a 30-min application of 20 nM TTQ APD 90 was increased from 53.02 + 1.76 to 56.13 + 1.48 ms (P , 0.05). The ERP was also increased from 39.17 + 1.30 to 41.17 + 1.47 ms, but with no significant change ( Figure 6F) . There was no significant change in LVDP and pacing threshold (data not shown).
Discussion
In this study, we investigate the expression and possible function of GIRK channels in the ventricle. The major findings are as follows: (i) GIRK4 proteins are localized at the surface membrane in mice, rat, and human ventricle. (ii) GIRK channel activation via A 1 -R or M 2 -R signalling pathway has an effect both on the RMP and on the length and refractoriness of the ventricular action potential. (iii) Inhibition of intrinsic GIRK channel activity likewise affects both the RMP and the ventricular action potential.
Presence of GIRK4 proteins in ventricle
In our previous study, we showed that GIRK1 and GIRK4 proteins are expressed in human ventricle, but at lower levels than in atria. 12 Cellular localization of GIRK channels in human ventricles has not previously been investigated.
By immunofluorescence experiments, we found GIRK4 proteins present in mouse, rat, and human ventricle. Surprisingly, GIRK4 protein is clearly localized in intercalated discs in rat and human. As Na v 1.5 channels, which are important for cardiac conduction, 23 are also targeted to intercalated discs, this localization is interesting from an arrhythmogenic perspective as a change in functional GIRK channels might also result in conduction changes in the myocardium and thereby increase the likelihood of re-entry arrhythmias. This may provide an explanation for the recent GIRK4 mutation we have linked to LQTS and serious arrhythmias, some of which were lethal. 12 Furthermore, confocal microscopy showed GIRK4 proteins to be heterogeneously expressed across the human ventricular wall. In line with this observation, a recent review suggested a widespread location of parasympathetic nerves and a relatively dense parasympathetic innervation of ventricular muscle in a range of mammals, including humans. 15 Thus, there may be significant vagal impact, through the GIRK channels, on the ventricle.
GIRK current contributes to ventricular repolarization
A number of previous studies have demonstrated that ACh and adenosine exert direct effects on action potentials in isolated ventricular myocytes in different species. 11, 13 Dobrzynski et al. 11 showed that both ACh and adenosine resulted in APD shortening in isolated ferret ventricular myocytes. Koumi et al. 13 showed that ACh shortens APD in isolated human ventricular myocytes, and atropine recovered the APD shortening. However, none of these studies has showed that the observed APD shortening is a direct effect of GIRK channel activation. In the present study, we have investigated the effect of GIRK channel activation and inhibition on ventricular repolarization by applying different specific receptor agonists and a specific channel blocker on rat ventricular tissue; thereby providing evidence that GIRK current contributes to ventricular repolarization. These observations are confirmed by the action potential experiments on mouse tissue, where wild-type mice ventricle responds like rat ventricular tissue, whereas GIRK4 KO ventricular tissue does not respond to muscarinic M 2 receptor activation.
In our study, both ACh and an adenosine agonist shortened the APD, and the APD shortening was recovered by either a selective receptor antagonist or a selective GIRK channel blocker in the presence of receptor activation. Previously, studies have shown that activation of the M 2 -R also directly reduces the I Ca,L currents and indirectly reduces the sodium-calcium exchanger currents, as well as inhibits I k1 currents. 11, 24, 25 In our study, by applying the selective GIRK channel blocker TTQ we observed that APD shortening was recovered back to the control level, demonstrating that the shortening of APD upon activation of A 1 -R or M 2 -R directly results from the activation of GIRK channels, and thereby at the same time indicating that an APD shortening due to an effect of ACh on I Ca,L , I k1 , or sodium-calcium exchanger currents is minor under the present experimental conditions. This is also confirmed by the fact that GIRK4 KO mice did not have any change in APD and RMP following stimulation. Hyperpolarization of cell membrane potentials, consistent with GIRK channel activation, has also been observed; TTQ recovered the hyperpolarization of RMPs.
While ACh is released following parasympathetic stimulation, adenosine is intrinsically accumulated in the intercellular space by either: (i) release of adenosine from the cell interior by sodium-dependent transporters or (ii) release of ATP that is sequentially cleaved by ectoAT-Pases/apyrases and ectonucleotidases. 26 Adenosine accumulates to high levels in hypoxic tissue, 27 but is also formed during normal heart contraction. 28, 29 It is thereby likely that GIRK channel activation in ventricles might occur via A 1 -R activation in the normal beating heart, and that GIRK channels profoundly contribute to the APD shortening during cardiac ischaemia.
When applying the GIRK channel blocker TTQ without exogenous receptor activation a depolarization of RMP followed the prolongation of APD. This indicates that GIRK channels have substantial basal activity and contribute to both ventricular repolarization and RMP. Dobrev et al. 3, 30, 31 reported that carbachol-induced GIRK current is downregulated in chronic atrial fibrillation patients, whereas the carbacholindependentconstitutively active GIRK current is up-regulated together with increased I k1 current. Consistent with this, a tachypaced dog model study has shown that atrial tachycardia increases agonist-independent constitutive I K,ACh single-channel activity by enhancing spontaneous channel opening, as well as associated ERP abbreviation and tertiapinsuppressible AF promotion. 32 Because GIRK channels, as I K1 , have the ability to hyperpolarize cell membranes and thereby indirectly release the voltage-dependent sodium channel from inactivation, the basal activity of GIRK channels may be of particular importance for the promotion of arrhythmias under pathophysiological conditions.
Limitations
The cardiac GIRK current in atria is primarily found to be carried by a heterotetramer of GIRK1 and GIRK4, though GIRK4 can assemble into functional homotetramer. 2, 33 In this study, we investigated the ventricular GIRK1 expression in mice, rat, and humans. However, none of the anti-GIRK1 antibodies provided specific staining in immunofluorescence experiments, as determined by use of GIRK1 KO mice tissue as a negative control. Hence, future studies to determine the ventricular GIRK1 localization are needed to delineate whether ventricular GIRK1 proteins co-localize with GIRK4. Finally, with respect to the effect of intrinsic GIRK channel activity, we cannot rule out that endogenous release of adenosine or intrinsic activity of A 1 receptor might contribute to our finding.
Conclusion
GIRK4 proteins are expressed in mice, rat, and human ventricle, although in different patterns. Electrophysiological experiments show that GIRK channels contribute to ventricular repolarization both with and without receptor activation, suggesting that GIRK current might be of greater physiological and pathophysiological relevance in ventricles than previously thought. Adenosine may be the most important endogenous activator of GIRK currents in the cardiac ventricle.
Supplementary material
Supplementary material is available at Cardiovascular Research online.
